Institutional members access full text with Ovid®

Share this article on:

Human Papillomavirus DNA and Pap Tests: The Need for Cotesting in Opportunistic Setting During the Transition Time

Mariani, Luciano MD1; Sideri, Mario MD2; Costa, Silvano MD3; Cristoforoni, Paolo MD4; Origoni, Massimo MD5; Preti, Mario MD6Italian HPV Study Group

Journal of Lower Genital Tract Disease: July 2013 - Volume 17 - Issue 3 - p 362–365
doi: 10.1097/LGT.0b013e31826f24c0
Comment Letter

The introduction of a cotesting strategy in the opportunistic setting could represent the best option in the transition time from cytology to HPV DNA–based screening.

1Department of Gynecological Oncology, Regina Elena Institute, Roma; 2Department of Gynecological Oncology, European Institute of Oncology, Milano; 3Department of Obstetrics and Gynecology, S. Orsola-Malpighi University Hospital, Bologna; 4Department of Gynecological Oncology, Istituto Nazionale per la Ricerca sul Cancro, Genova; 5Department of Obstetrics and Gynecology, Vita Salute San Raffaele University School of Medicine, Milano and 6Department of Gynecology and Obstetrics, University of Torino, Torino, Italy

Reprint requests to: Mario Preti, MD, Corso Orbassano 227, 10137 Torino, Italy. E-mail:

The authors have declared they have no conflicts of interest.

Copyright © 2013 by the American Society for Colposcopy and Cervical Pathology